GSK
Tuesday, June 04, 2024
Company Presentation
![Multiline Global Biopharma](https://cdn.asp.events/CLIENT_BIO_7BB99CBA_BAD1_B8C8_CF9F25DA29A80CC6/sites/BIOIC-2024/media/icons/seminars/blank.png)
Company Presentation Theater 2
We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We focus on science of the immune system and advanced technologies, investing in 4 core therapeutic areas (Infectious Diseases, HIV, Respiratory/ Immunology and Oncology) to impact health at scale.
![GSK](https://www.abstractscorecard.com/uploads/Tasks/upload/21754/XDQDGWMO-1819202-1-JPG(2).png)
Company Website:
http://www.gsk.com
Lead Product in Development:
Shingrix
Trelegy Ellipta
Dovato
Nucala
Triumeq
Exchange
NYSE
London
Ticker
GSK
Company HQ City
Brentford
Company HQ State
Middlesex
Company HQ Country
United Kingdom
CEO/Top Company Official
Emma Walmsley
Development Phase of Primary Product
Multiple Products in Market
Primary Speaker